Old software and poor data quality cause both revenue losses and extra expense to reconcile claims. Will serialized packages provide an eventual cure?
While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD
Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them
Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs, also objects to restrictions on wholesale-distribution
In competing for pharmacy business, AmerisourceBergen, Cardinal Health and McKesson offer improved access to branded and generic products
Long in the making, could become finalized before the end of the year
Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps. Next up: unused pharmaceutical returns
Capsugel will provide nano-encryption for capsules through technology license
Forbes magazine survey finds top nine drugs, all costing >$200,000 annually
Sustainability initiatives add to the complexity of managing reverse logistics for life sciences products
Only sites certified by NABP (in the US) and CIPA (Canada) will be allowed to purchase AdWords
The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients
Drugmaker will collaborate with Web startup to develop personalized healthcare plans
USDA program started around when the FDA program did, and encountered similar problems
Patient Outcomes Research Moves Drug Development Beyond Clinical Results
Latest 10-year BLS projection sees moderate growth in US employment—except for ‘top executives’
While time- and temperature-sensitive biopharma shipping will grow dramatically in coming years, the capacity of air freight carriers is becoming constrained
Two industry communications agencies hope an online collaboration will lead to joint service offerings
Long in the making, could become finalized before the end of the year
European anticounterfeiting project tests end-to-end authentication
Launch includes a delayed-release formulation, in-house and contract sales force, a REMS program and a patient-adherence program
Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs; also objects to restrictions on wholesale-distribution
CRM vendor invests in data sources to upgrade its offerings for life sciences regulatory and marketing operations
Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps
Participants will meet quarterly throughout the year to create supply chain use-scenarios with GS1 standards
Updated survey finds some improvements, but little overall progress since a 2006 survey
In the past year, FDA has imposed REMS programs for one out of four new drug approvals
Impersonators appear to be operating from the Dominican Republic
Early November recall of musty-smelling product is expanded from five to 54 lots; McNeil attributes the problem to packaging storage materials